People

Search Language

English | Use language selector above (below, on mobile) to search additional languages
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(e)

1351 items matching filters

Kimberly M. Loocke Senior Associate

San Francisco

Kimberly holds a Certified Public Accountant license and worked as a senior tax associate for Deloitte Tax, LLP prior to law school.

423628

Practice:

  • International Trade and Investment

Allison Lofgren Bradham Associate

Washington, D.C.

Allison advises clients on U.S. export controls and economic sanctions. She also has experience advising clients on trade compliance due diligence in corporate transactions. Allison counsels clients on foreign investment reviews, including matters involving the Committee on Foreign Investment in the United States (CFIUS).

391632

Practice:

  • International Trade and Investment
  • FCPA & Anti–Corruption
  • Anti‐Money Laundering and Bank Secrecy Act
  • Mergers & Acquisitions
  • Responsible Business
  • Strategic Advisory & Government Enforcement (SAGE)

Jeanine P. McGuinness Partner

Washington, D.C.

Jeanine’s clients include major U.S. and foreign financial institutions, and pharmaceutical, technology, defense, space, telecommunications, energy, and infrastructure companies, among others.

Examples of Jeanine’s experience include:

  • Represents clients in preparing voluntary self-disclosures, administrative subpoena responses and license applications, and represents companies in connection with enforcement actions by the Treasury Department’s Office of Foreign Assets Control (OFAC)
  • Provides policy and compliance advice to clients affected by frequent changes in U.S. sanctions, including sanctions targeting Iran, Cuba, and Russia/Ukraine
  • Assists foreign purchasers of U.S. companies in national security reviews, including navigating the CFIUS process, through preparation of notices, meetings with CFIUS member agencies, advising on follow-on investigations, and negotiating and implementing mitigation agreements
  • Assists clients in developing and updating economic sanctions, anti-money laundering, and anti-corruption compliance policies and procedures
  • Represents financial institutions in connection with U.S. federal and state enforcement actions regarding compliance with U.S. anti-money laundering laws and regulations
  • Represents lenders, underwriters, borrowers, and issuers in international lending and capital markets transactions regarding sanctions, anti-corruption, and anti-money laundering issues
  • Advises a U.S. trade association and its member banks regarding U.S. sanctions, anti-corruption, and anti-money laundering issues in lending transactions, and prepares guidance for the industry on these matters
  • Advises financial institutions on the application of U.S. anti-money laundering regulations, with specific emphasis on customer identification program (CIP)/know your customer (KYC)/customer due diligence (CDD) requirements and suspicious activity reporting requirements
  • Regularly advises private equity and hedge funds regarding compliance with U.S. anti-money laundering and sanctions laws and regulations, including with respect to appropriate provisions in subscription materials and enhanced due diligence on high-risk investors
  • Advises clients regarding sanctions-related inquiries from the Securities and Exchange Commission (SEC) and state agencies implementing divestment laws and assists clients in preparing sanctions-related disclosure for inclusion in annual reports to the SEC

Jeanine is ranked in both the CFIUS Experts and Export Controls & Economic Sanctions categories by Chambers USA in 2019, 2020, 2021, and 2022. An interviewee had this to say of their experience working with Jeanine, “I am continuously impressed by her extensive knowledge, excellent communication skills and her ability to wrap her subject matter expertise around the details of the matter and then drive conclusions or recommendations for next steps."

450684

Practice:

  • Strategic Advisory & Government Enforcement (SAGE)
  • Cyber, Privacy & Data Innovation

Carly Owens Managing Associate

New York

Carly counsels clients across several sectors, including health technology, financial services, private equity, insurance, and technology on a range of United States (U.S.) federal and state privacy laws, including, but not limited to:

  • Illinois Biometric Information Privacy Act (BIPA) and other biometric privacy laws
  • Health Insurance Portability and Accountability Act (HIPAA)
  • Washington My Health My Data Act and other state health privacy laws
  • U.S. state privacy laws in California, Colorado, Connecticut, Utah, Virginia and other states
  • Telephone Consumer Protection Act (TCPA)
  • Controlling the Assault of Non-Solicited Pornography And Marketing Act (CAN-SPAM)
  • New York Department of Financial Services Cybersecurity Regulation 500

She also prepares clients for regulatory inquiry and government investigation and provides assessments of privacy and security practices for companies carrying out due diligence in the context of corporate transactions. Carly also maintains an active pro bono practice, which has included helping clients in immigration and criminal justice matters.

Carly has obtained the Certified Information Privacy Professional - United States (CIPP/US) designation from the International Association of Privacy Professionals.

442001

Practice:

  • Antitrust & Competition
  • Strategic Advisory & Government Enforcement (SAGE)

Dr. Benedikt Kamann Associate

Düsseldorf

He advises companies on German and European antitrust and competition law, in particular on merger control, compliance, internal investigations, cartels and abuse of dominance.

Furthermore, Benedikt advises on foreign trade law issues, in particular on investment review proceedings before the German Federal Ministry for Economic Affairs and Climate Action.

Prior to joining Orrick, he worked as a research assistant at a leading German law firm and as a trainee lawyer in the antitrust team of a leading international law firm, at a U.S. law firm in its Los Angeles office, and at the German Federal Parliament in the department for EU policy issues.

461799

Practice:

  • Antitrust & Competition

Neetu Ahlawat Associate

London

Neetu’s practice encompasses merger control and foreign direct investment, having represented clients in several big-ticket cases requiring complex remedies. She provides guidance on compliance and conducts a range of behavioural investigations for clients across multiple sectors.

Before joining Orrick, Neetu was part of the top-tier competition practice at one of India's largest law firms.

353518

Practice:

  • Mergers & Acquisitions
  • Technology Companies Group
  • Corporate Governance

Jamie Kamen Baroff Senior Associate

New York

Jamie's practice focuses on domestic and cross-border mergers and acquisitions, advising companies on formation and equity financings, and corporate governance matters.

403431

Practice:

  • Technology & Innovation Sector
  • Technology & Innovation
  • Technology Transactions
  • Intellectual Property
  • Strategic Advisory & Government Enforcement (SAGE)

Sarah Schaedler Partner

San Francisco

Sarah’s practice focuses on structuring and negotiating the intellectual property aspects of complex corporate transactions, including mergers and acquisitions, business divestitures and commercial transactions where software and technology are the principal assets. Sarah also advises on intellectual property and technology contracts related questions in the context of Artificial Intelligence (AI).

Sarah routinely advises on carve-outs and business separation transactions and helps clients with structuring and implementing their intellectual property and technology separation roadmap.

Sarah has counseled several companies in their preparation for a divestiture and understands the issues a buyer is focused on in the context of intellectual property matters. She regularly helps companies implement remediation steps around their intellectual property assets to help them to a successful closing.

She has significant experience advising private equity funds on investments involving companies that are driven by technology & innovation, as well as intellectual property reliant consumer product companies and companies that are stepping into digitalization.

Sarah is also a member of Orrick’s AI leadership group and involved in thought leadership projects related to AI matters on corporate transactions.

Educated and trained in Germany, France and the United States, Sarah’s international experience provides her with additional knowledge on cross-border transactions and international matters.

454161

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Emily Brodkin Managing Associate

Boston

Providing counsel focused on both preventing and solving problems, she has represented established and emerging digital health companies, hospitals, health systems, and pharmaceutical and device manufacturers. Emily’s experience includes involvement in fraud and abuse issues, data privacy, telehealth, and scope of practice matters.

453686

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Amy M. Joseph Partner

Boston

Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.

Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.

In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.

A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.

Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”

Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.

472572

Practice:

  • Litigation & IP
  • Securities Litigation
  • White Collar, Investigations, Securities Litigation & Compliance
  • Financial Services Litigation
  • Life Sciences & HealthTech
  • Energy & Infrastructure

Eddie Han Partner

Silicon Valley

Clients turn to Eddie for strategic counsel on their most significant exposures. He has represented biopharmaceutical and molecular diagnostics companies in securities class actions and proxy contest disputes, advised global technology leaders and financial institutions in internal investigations and M&A-related disputes, and defended numerous clients in regulatory investigations. His experience also includes matters involving the Foreign Corrupt Practices Act (FCPA).

Eddie is frequently sought for his expertise in responding to investigations by the Department of Justice (DOJ), Securities and Exchange Commission (SEC), and other federal and state agencies, including self-regulatory organizations. He regularly guides audit and special committees through internal investigations related to SOX compliance, revenue recognition, and executive compensation, and defends clients in insider trading and securities fraud matters.

Recognized by Legal 500 for Securities Litigation: Defense and M&A Litigation: Defense and by Best Lawyers in America for Securities Litigation, Eddie is a regular speaker on securities litigation topics and has been quoted in leading periodicals. He has authored numerous articles on securities enforcement and litigation, sharing insights that reflect his deep understanding of the evolving securities litigation and regulatory landscape.